Dose Adjustment of Poly (ADP‑Ribose) Polymerase Inhibitors in Patients with Hepatic or Renal Impairment

por Zhao, Dehua, Long, Xiaoqing, Wang, Jisheng
Publicado 2022

Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System

por Zhao, Dehua, Long, Xiaoqing, Zhou, Jiping, Wang, Jisheng
Publicado 2023

Dose adjustment for tyrosine kinase inhibitors in non-small cell lung cancer patients with hepatic or renal function impairment

por Zhao, Dehua, Chen, Jing, Long, Xiaoqing, Wang, Jisheng
Publicado 2021

Aidi injection combined with chemotherapy in the treatment of cancer patients: a systematic review of systematic reviews and meta-analyses

por Zhao, Dehua, Long, Xiaoqing, Chen, Jing, Wang, Jisheng
Publicado 2021

Pharmacokinetic-Based Drug–Drug Interactions with Anaplastic Lymphoma Kinase Inhibitors: A Review

por Zhao, Dehua, Chen, Jing, Chu, Mingming, Long, Xiaoqing, Wang, Jisheng
Publicado 2020

Elevated hsa‐miR‐590‐3p expression down‐regulates HMGB2 expression and contributes to the severity of IgA nephropathy

por Zhai, Yaling, Qi, Yuanyuan, Long, Xiaoqing, Dou, Yanna, Liu, Dong, Cheng, Genyang, Xiao, Jing, Liu, Zhangsuo, Zhao, Zhanzheng
Publicado 2019

The soluble VEGF receptor sFlt-1 contributes to endothelial dysfunction in IgA nephropathy

por Zhai, Yaling, Liu, Youxia, Qi, Yuanyuan, Long, Xiaoqing, Gao, Jingge, Yao, Xingchen, Chen, Yazhuo, Wang, Xinnian, Lu, Shan, Zhao, Zhanzheng
Publicado 2020

Age is not a barrier to good outcomes following ambulatory high ligation and stripping for varicose veins: A prospective cohort study

por Chen, ChuWen, Cai, YuTing, Long, XiaoQing, Fan, Xiang, Yuan, Ding, Yang, Yi, Huang, Bin, Zhao, JiChun, Ma, YuKui
Publicado 2019